Clinical Research on Zishengukang Pill(滋肾骨康丸)Used to Treat Delayed Union of Fracture

Objective:To observe the curative effect of Zishengukang Pill(滋肾骨康丸) on delayed union of fracture.Methods:Sixty-four patients with delayed union of fracture were randomly divided into a control group of 32 cases treated with Western medicine and a treatment group of 32 cases treated with Western medicine and Zishengukang Pill.After 3 courses of treatment with 30 days as a course,the curative effects in the two groups were evaluated and their clinical symptoms,union rate and union time of fracture were compared.Results:The treatment resulted in cure in 25 cases,improvement in 6 cases and ineffectiveness in 1 case with the effective rate at 96.8% in the treatment group,higher than 81.3% in the control group(P<0.05).The union rate of fracture in the treatment group was higher than that in the control group(34.3% vs.12.5%,P<0.05).The union time of fracture in the treatment group was shorter than that in the control group((4.0±1.7) months vs.(5.0±1.4) months,P<0.05).Conclusion:Zishengukang Pill with obvious curative effect in the treatment of delayed union of fracture is worth popularizing.

滋肾骨康丸治疗骨质疏松症的临床研究

目的:观察滋肾骨康丸治疗骨质疏松症的临床疗效,并对该药的作用机理进行探讨。方法:将60例病人随机分为治疗组(滋肾骨康丸组)及对照组(西药组),根据2组骨密度、骨痛、中医证候结果及临床总体疗效为指标进行比较。结果:治疗组治疗后总有效率为95.8%,对照组治疗后总有效率为75.3%,差异有统计学意义(P<0.01);2组治疗前后骨密度无显著性差异(P>0.05);治疗组治疗后骨痛有效率为92.5%,优于对照组的73.3%(P<0.05);治疗后治疗组中医证候有效率为100%,明显优于对照组的53.3%(P<0.01)。结论:滋肾骨康丸能显著改善骨痛、肾虚证候,总体改善临床症状,具有较好的治疗作用,值得进一步推广。

滋肾骨康丸结合运动疗法治疗膝关节骨性关节炎临床研究

目的:观察应用滋肾骨康丸结合运动疗法治疗膝关节骨性关节炎的临床疗效。方法:100例膝关节骨性关节炎患者随机分为治疗组50例和对照组50例。对照组采用单纯运动疗法,治疗组在对照组的基础上加服滋肾骨康丸,30 d后观察临床疗效。结果:治疗组有效率为92.0%,对照组有效率为84.0%,两组有效率比较,差异有统计学意义(P<0.05);治疗组远期复发率为20.0%,对照组远期复发率为26.0%,两组远期复发率比较,差异有统计学意义(P<0.05)。结论:滋肾骨康丸结合运动疗法治疗膝关节骨性关节炎疗效确切,复发率低。

滋肾骨康丸对去卵巢大鼠骨质疏松症作用的实验研究

目的:探讨滋肾骨康丸对去卵巢大鼠骨质疏松症的治疗作用。方法:选择雌性大鼠50只,随机分为空白组、模型组、高剂量组、低剂量组和尼尔雌醇组5组,每组10只,造模后两周开始灌胃给药,治疗组按照大(12g/kg)、小(6g/kg)给以滋肾骨康丸,阳性对照组给以尼尔雌醇1.0g/kg,空白组与模型组给以生理盐水,共12周。试验结束后,取样本测骨密度、骨矿含量和血清E2含量的变化。结果:与空白组比,模型组测骨密度、骨矿含量和血清E2含量均明显降低(P<0.01);与模型组比,高剂量组、低剂量组和尼尔雌醇组均可使骨密度、骨矿含量和血清E2含量升高(P<0.01)。结论:结果表明,滋肾骨康丸具有较好的治疗骨质疏松症的作用,值得进一步的开发和利用。

Treatment of osteoporotic vertebral compressive fractures with percutaneous kyphoplasty and oral Zishengukang

OBJECTIVE:To observe the therapeutic effect of percutaneous kyphoplasty(PKP) and oral Zishengukang(ZSGK) for the treatment of osteoporotic vertebral compression fractures(OVCFs).METHODS:Seventy patients were randomly divided into a control group(PKP group) and an experimental group(PKP plus ZSGK group).The 35 patients in the experimental group were prescribed 6 g oral ZSGK three times a day for 90 days after PKP.Visual analog pain scale(VAS),Oswestry functional score,vertebral height and Cobb's angle were recorded and compared before treatment and at one week,one month and three months after treatment.RESULTS:Vertebral height and Cobb's angle significantly improved and VAS and Oswestry functional score were significantly lower in both groups after PKP than pre-operatively(P<0.01).Three months after treatment,VAS and Oswestry functional score in the experimental group were lower than controls(P<0.05),even though vertebral height and Cobb's angle were comparable(P>0.05).CONCLUSION:PKP combined with oral ZSGK provide superior short-term and long-term symptom control after OVCF than PKP alone.

滋肾骨康丸对骨质疏松性股骨颈骨折术后愈合及髋关节功能的影响

目的：观察滋肾骨康丸对骨质疏松性股骨颈骨折术后骨折愈合及髋关节功能的影响。方法：将64例股骨颈骨折术后患者随机分为对照组和观察组，每组各32例。对照组术后给予常规治疗，观察组在对照组基础上口服滋肾骨康丸。术后随访6～12个月，观察术后第1个月、3个月和6个月两组骨密度值及骨折愈合情况，评价髋关节活动功能。结果：与术前相比较，术后第3个月、第6个月两组股骨颈骨密度值均有不同程度增加；观察组骨密度值高于对照组（P〈0．05）。术后两组髋关节功能均有不同程度改善，术后第3个月、第6个月Harris评分明显升高（P〈0．01）；其中术后6个月时，观察组Harris评分高于对照组（P〈0．05）。结论：滋肾骨康丸可有效增加骨质疏松性股骨颈骨折骨密度值、促进骨折愈合，改善髋关节活动功能。